JOHANNESBURG (Reuters) – South Africa has decided to temporarily suspend the rollout of Johnson & Johnson’s COVID-19 vaccine, its health minister said on Tuesday, after U.S. federal health agencies recommended pausing its use because of rare cases of blood clots in six people inoculated with it.
Health Minister Zweli Mkhize told a briefing that in South Africa there had not been reports of such clots after vaccination with J&J’s vaccine.
He added the country had secured an additional 10 million COVID-19 vaccine doses from Pfizer.
(Reporting by Alexander Winning; Editing by Olivia Kumwenda-Mtambo; Editing by Chris Reese)
